100.39
price down icon0.44%   -0.44
after-market Handel nachbörslich: 100.39
loading

Axsome Therapeutics Inc Aktie (AXSM) Neueste Nachrichten

pulisher
10:00 AM

Axsome Therapeutics (AXSM) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - Yahoo Finance

10:00 AM
pulisher
08:37 AM

What makes Axsome Therapeutics Inc. stock price move sharplyStock Strategy Planner To Watch Now - jammulinksnews.com

08:37 AM
pulisher
06:49 AM

Envestnet Asset Management Inc. Sells 10,086 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat

06:49 AM
pulisher
06:48 AM

Axsome Therapeutics (AXSM) to Release Earnings on Monday - MarketBeat

06:48 AM
pulisher
06:35 AM

Why is Axsome Therapeutics Inc. stock attracting strong analyst attentionAchieve rapid portfolio growth with expert guidance - jammulinksnews.com

06:35 AM
pulisher
05:19 AM

Royce & Associates LP Reduces Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat

05:19 AM
pulisher
05:01 AM

What catalysts could drive Axsome Therapeutics Inc. stock higher in 2025Invest confidently with real-time data analysis - jammulinksnews.com

05:01 AM
pulisher
04:46 AM

Does Axsome Therapeutics Inc. stock perform well during market downturnsGet timely alerts on market opportunities - jammulinksnews.com

04:46 AM
pulisher
03:50 AM

Universal Beteiligungs und Servicegesellschaft mbH Makes New Investment in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat

03:50 AM
pulisher
03:18 AM

Cwm LLC Trims Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat

03:18 AM
pulisher
02:14 AM

Y Intercept Hong Kong Ltd Makes New $1.49 Million Investment in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat

02:14 AM
pulisher
Jul 27, 2025

How strong is Axsome Therapeutics Inc. company’s balance sheetFree Market Dynamics Reports - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Axsome Therapeutics Inc. Company’s Quarterly Earnings Growth: What the Numbers SayFree Stock Market Query - Metal.it

Jul 27, 2025
pulisher
Jul 27, 2025

Published on: 2025-07-27 23:41:07 - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Is Axsome Therapeutics Inc. stock overvalued or undervaluedDynamic profit expansion - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

When is Axsome Therapeutics Inc. stock expected to show significant growth - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How does Axsome Therapeutics Inc. generate profit in a changing economyUnprecedented profit potential - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Knights of Columbus Asset Advisors LLC Sells 4,957 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat

Jul 27, 2025
pulisher
Jul 26, 2025

Axsome Therapeutics (NASDAQ:AXSM) Shares Down 5.6%Here's Why - MarketBeat

Jul 26, 2025
pulisher
Jul 25, 2025

Axsome Therapeutics: Navigating Setbacks with a Strong Pipeline and Analyst Confidence - AInvest

Jul 25, 2025
pulisher
Jul 25, 2025

Axsome: Some Recent Setbacks, Some Recent Wins — Still A Buy (NASDAQ:AXSM) - Seeking Alpha

Jul 25, 2025
pulisher
Jul 25, 2025

Axsome Therapeutics Hosts Frontiers in Brain Health R&D Day Reviewing Industry-Leading Late-Stage CNS Pipeline - ADVFN Brasil

Jul 25, 2025
pulisher
Jul 25, 2025

Why Axsome Therapeutics Inc. stock is on top investor watchlistsSuperior stock selection - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about Axsome Therapeutics Inc. stockOutstanding capital growth - Autocar Professional

Jul 25, 2025
pulisher
Jul 25, 2025

Axsome Therapeutics Inc. Stock Analysis and ForecastRapid growth trajectories - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Axsome Therapeutics, Inc. (NASDAQ:AXSM) Stake Raised by Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. - MarketBeat

Jul 25, 2025
pulisher
Jul 24, 2025

RBC Capital Sticks to Their Buy Rating for Axsome Therapeutics (AXSM) - The Globe and Mail

Jul 24, 2025
pulisher
Jul 24, 2025

New York State Common Retirement Fund Has $3.92 Million Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat

Jul 24, 2025
pulisher
Jul 24, 2025

Is Axsome Therapeutics Inc. stock overhyped or has real potentialUnstoppable trading performance - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

How high can Axsome Therapeutics Inc. stock price go in 2025Breakthrough investment results - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

How To Trade (AXSM) - news.stocktradersdaily.com

Jul 24, 2025
pulisher
Jul 24, 2025

Axsome Therapeutics Settles SUNOSI (Solriamfetol) Patent Litigation With Hetero Labs Ltd. - 富途牛牛

Jul 24, 2025
pulisher
Jul 24, 2025

Is This Stock a Buy After Soaring by 20% in 1 Day? - AOL.com

Jul 24, 2025
pulisher
Jul 24, 2025

2 Top Stocks I Wouldn't Hesitate to Invest $1,000 in Right Now - MSN

Jul 24, 2025
pulisher
Jul 24, 2025

Q3 EPS Estimate for Axsome Therapeutics Raised by Analyst - MarketBeat

Jul 24, 2025
pulisher
Jul 24, 2025

Legato Capital Management LLC Buys New Holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat

Jul 24, 2025
pulisher
Jul 24, 2025

Is Axsome Therapeutics Inc. a good long term investmentGame-changing returns - Autocar Professional

Jul 24, 2025
pulisher
Jul 23, 2025

Leerink Partners Keeps Bullish Stance on Axsome Therapeutics with Buy Rating - AInvest

Jul 23, 2025
pulisher
Jul 23, 2025

Lindbrook Capital LLC Cuts Holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat

Jul 23, 2025
pulisher
Jul 23, 2025

Optimistic Outlook for Axsome Therapeutics: Promising Pipeline and Potential Sales Growth Drive Buy Rating - TipRanks

Jul 23, 2025
pulisher
Jul 22, 2025

Axsome Therapeutics Breaks Below 200-Day Moving AverageNotable for AXSM - Nasdaq

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Axsome Therapeutics Inc. stock priceUnprecedented profit potential - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Readystate Asset Management LP Invests $6.95 Million in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat

Jul 22, 2025
pulisher
Jul 22, 2025

ALKS Down Despite Positive Top-Line Data From Narcolepsy Study - The Globe and Mail

Jul 22, 2025
pulisher
Jul 22, 2025

Axsome Therapeutics stock rating reiterated by Cantor Fitzgerald - Investing.com Canada

Jul 22, 2025
pulisher
Jul 22, 2025

Mizuho reiterates Outperform rating on Axsome Therapeutics stock By Investing.com - Investing.com South Africa

Jul 22, 2025
pulisher
Jul 22, 2025

Axsome Therapeutics: Promising Growth Driven by Robust Pipeline and Strategic Fit - TipRanks

Jul 22, 2025
$23.09
price down icon 1.32%
$37.06
price up icon 1.06%
$101.75
price down icon 2.12%
$27.45
price down icon 4.26%
$112.79
price down icon 2.19%
biotechnology ONC
$294.51
price up icon 1.04%
Kapitalisierung:     |  Volumen (24h):